OX40 ligand (OX40L) and high-sensitivity C-reactive protein (hs-CRP) play important roles in the pathogenesis of atherosclerosis. In this study, consecutive patients with acute coronary syndrome (ACS; n = 90) or stable angina (SA; n = 40) and healthy control subjects (n = 50) were evaluated to assess plasma OX40L and serum hs-CRP levels in local coronary plaque and the femoral artery. OX40L and hs-CRP levels in the femoral artery were significantly higher in patients with ACS compared with controls. OX40L and hs-CRP levels in local coronary plaque (OX40L c and hs-CRP c , respectively) were significantly higher in ACS than in SA patients. OX40L and hs-CRP levels were positively correlated with each other and were also correlated with fibrinogen levels. The number of complex lesions was correlated with OX40L c and hs-CRP c levels. It is concluded that the OX40L c level was highly sensitive for evaluating the inflammatory response in ACS and elevated levels of OX40L c may be a valuable predictive marker for increased risk of atherosclerotic progression in ACS patients.
Introduction
Atherosclerosis is the pathological basis of acute coronary syndrome (ACS) and is considered to be a chronic (auto)inflammatory disease. 1 -3 A growing appreciation of the role of inflammation in atherogenesis has focused attention on circulating levels of inflammatory biomarkers. Several circulating markers of inflammation, such as C-reactive protein (CRP), have consistently been shown to be associated with atherosclerotic disease and the occurrence of ACS. CRP, the classic acutephase protein, is a sensitive marker of inflammation, and increased CRP has been associated not only with coronary artery JZ Shi, LY Wang, Y Zhu et al. OX40L and hs-CRP in acute coronary syndrome and angina disease (CAD) and diabetes mellitus but also with mortality. 4 -7 Understanding of the processes that initiate and maintain inflammation has increased with the characterization of new disease pathways in the adaptive and innate immune systems. One such pathway is the receptor-ligand pair OX40-OX40 ligand (OX40L), which has shown an association with atherosclerosis in both mice and humans. 8 Interruption of the OX40-OX40L interaction has been shown to ameliorate several autoimmune-like diseases 9 -11 and reduce atherogenesis in mice deficient in low-density lipoprotein receptor. 12 Previous studies have documented the role of OX40L and high-sensitivity CRP (hs-CRP) in peripheral blood on the development of atherosclerosis; 1, 13 to our knowledge, however, levels in arterial blood and local coronary plaque have not been researched. In this study the levels of plasma OX40L and serum hs-CRP were determined in local coronary plaque and the femoral artery with the aim of investigating differences in inflammatory effect. The correlations between OX40L and hs-CRP levels, and their correlations with fibrinogen level and coronary artery stenoses, were also assessed.
Patients and methods

PARTICIPANTS
Patients and healthy controls were involved in the study over a period of 12 months. Patients were classified into two groups: an ACS group and a group with stable angina (SA). The ACS group consisted of (i) patients with unstable angina who experienced new onset angina or worsening angina or rest angina within 1 month, but did not have evidence of myocardial necrosis using enzymatic criteria, and (ii) patients with recent myocardial infarction (defined as occurrence within the preceding 4 weeks).
Diagnosis of myocardial infarction was based on typical chest pain and ST segment elevation in at least two contiguous electrocardiographic leads. The SA group consisted of patients who had experienced no changes in frequency, duration or intensity of angina symptoms within the preceding 4 weeks. The healthy control group consisted of sex-and age-matched subjects (healthy volunteers, persons who underwent physical examination and patients who experienced chest pain but were proved to have normal coronary arteries by coronary angiography). Exclusion criteria were infection, tumours and liver or kidney disease. The Health Funding Authority Ethics Committee associated with the Provincial Hospital affiliated to Shandong University, Jinan, China approved the study protocol and written informed consent was obtained from each subject.
BLOOD SAMPLING AND ENZYME IMMUNOASSAY
During percutaneous coronary intervention, blood samples were collected from local coronary plaque, using a suction catheter, and also from the femoral artery. Blood to be used for assessment of plasma OX40L levels was drawn into a tube containing ethylenediaminetetraacetic acid disodium (Na 2 -EDTA; final concentration 0.1%), immediately centrifuged for 10 min at 1000 g at 4°C and stored at −80°C until analysis. Samples were thawed only once. Blood to be used for assessment of serum hs-CRP levels was drawn into a tube containing coagulant and were then sent to the clinical laboratory for determination.
Levels of plasma OX40L were determined using a rat antihuman OX40L enzymelinked immunosorbent assay (ELISA) kit (Assay Designs, Ann Arbor, MI, USA), JZ Shi, LY Wang, Y Zhu et al. OX40L and hs-CRP in acute coronary syndrome and angina according to the manufacturer's instructions, with a detection limit of 1.0 pg/ml; OX40L > 8.5 ng/ml was defined as an elevated level. Serum hs-CRP levels were measured by a previously validated 14 particle-enhanced immunonephelometric assay (Hitachi 911 ® ; Boehringer Mannheim, Mannheim, Germany). A concentration of > 3 mg/l was defined as an elevated level. Other laboratory measurements were made using standard methods; fibrinogen was measured using the clotting method. 15 
CORONARY ANGIOGRAPHY
Coronary angiography was performed using a femoral approach with 6 Fr diagnostic catheters. Images were recorded in multiple projections for left and right coronary arteries on 35 mm cine film. All coronary stenoses were assessed by two experienced cardiologists who had no knowledge of the levels of OX40L and hs-CRP or the identity and clinical characteristics of the patients. Complex lesions were defined by the following features: (i) irregular morphology or scalloped borders, or both; (ii) overhanging or abrupt edges perpendicular to the vessel wall; (iii) ulceration; (iv) the presence of filling defects consistent with intracoronary thrombus. Gensini's 16 integral system was used to assess quantitatively the degree of stenosis for each coronary vascular lesion.
STATISTICAL ANALYSES
The data were analysed using SPSS ® version 16.0 (SPSS, Chicago, IL, USA). Quantitative data are presented as mean ± SD and categorical data as percentages. Data with a normal distribution were compared using the t-test and analysis of variance, while data with a non-normal distribution were compared using the Wilcoxon nonparametric test. Discrete variables are presented as total number (percentage) and were compared using the χ 2 test. Receiver operating characteristic (ROC) curves were constructed and the accuracy of predicting ACS was assessed using the area under the ROC curve and 95% confidence limits. Relationships were explored using Spearman's correlation technique. A P-value < 0.05 was considered to be statistically significant.
Results
PARTICIPANT CHARACTERISTICS
Demographic and clinical characteristics of the study participants are shown in Table 1 .
The study included 130 patients with angiographically documented CAD (93 males and 37 females; mean ± SD age 60.74 ± 9.15 years). There were 90 patients in the ACS group (50 with unstable angina without evidence of myocardial necrosis and 40 with recent myocardial infarction) and 40 patients in the SA group. The healthy control group comprised 50 subjects.
The patients with CAD were significantly older (P = 0.005) and a greater number had diabetes mellitus (P = 0.001) compared with the control group. Levels of fibrinogen, indirect bilirubin and lipoprotein (a) were significantly different between the CAD group and the control group (P = 0.004, P = 0.010 and P < 0.001, respectively). The Gensini score, an indicator of the degree of coronary atherosclerosis, was significantly higher in the CAD group than in the control group (P < 0.001). Use of medications (aspirin, nitroglycerine, angiotensinconverting enzyme inhibitors, 3-hydroxy-3methylglutaryl-coenzyme A reductase inhibitors, β-blockers or calcium antagonists) was significantly greater in the ACS and SA groups than in the control group (P < 0.001 for all medications). The only significant difference between the ACS and SA groups OX40L and hs-CRP in acute coronary syndrome and angina 
2: Comparison between patients with acute coronary syndrome (ACS) or stable angina (SA) and healthy controls for OX40 ligand and high-sensitivity C-reactive protein concentrations in blood from the femoral artery (OX40L a and hs-CRP a , respectively) and from local coronary plaque (OX40L c and hs-CRP c , respectively) OX40L and hs-CRP in acute coronary syndrome and angina
was in the fibrinogen level (P = 0.007).
OX40L AND HS-CRP LEVELS
As shown in Table 2 , OX40L levels in blood samples from the femoral artery (OX40L a ) were significantly higher in patients with ACS compared with the control and SA groups (P < 0.001 for both differences). OX40L levels in local coronary plaque samples (OX40L c ) were significantly higher in the ACS group compared with the SA group (P < 0.001). The hs-CRP levels in serum samples from the femoral artery (hs-CRP a ) were significantly higher in patients with ACS compared with the control (P = 0.001) and SA (P = 0.039) groups. The hs-CRP levels in samples from local coronary plaque (hs-CRP c ) were significantly higher in the ACS group compared with the SA group (P = 0.001).
The OX40L c and hs-CRP c levels were significantly higher than the OX40L a and hs-CRP a levels, respectively, in both the ACS and the SA group (P < 0.01 for all differences).
ACCURACY OF OX40L C IN ACS PREDICTION
Elevated OX40L c was associated with the presence of ACS, with an area under the receiver operating characteristic (ROC) curve of 0.814 (95% CI 0.737 -0.891; P < 0.001). Elevated hs-CRP c was also associated with the presence of ACS, with an area under the ROC curve of 0.684 (95% CI 0.580 -0.788; P = 0.001), but this was significantly smaller than the area under the ROC curve for OX40L c (P < 0.001; Fig. 1 ), thus demonstrating a weaker discriminatory power than that of OX40L c . 
CORRELATIONS OF OX40L C AND OX40L C WITH HS-CRP C AND HS-CRP C
The level of OX40L c in patients with ACS showed a positive correlation with the level of serum hs-CRP c (r = 0.815, P < 0.001; Fig.  2A) . Similarly, the level of OX40L a in patients with ACS showed a positive correlation with the level of serum hs-CRP a (r = 0.788, P < 0.001; Fig. 2B ).
In the SA group, the level of OX40L c was also positively correlated with the level of serum hs-CRP c (r = 0.649, P < 0.001; Fig. 2C ) and the level of OX40L a was positively correlated with the level of serum hs-CRP a (r = 0.683, P < 0.001; Fig. 2D ).
CORRELATIONS OF OX40L AND HS-CRP WITH FIBRINOGEN
In patients with ACS, levels of OX40L c , OX40L a , hs-CRP c and hs-CRP a were significantly correlated with the level of fibrinogen (r = 0.824, P < 0.001; r = 0.806, P < 0.001; r = 0.871, P < 0.001 and r = 0.852, P < 0.001, respectively; data not shown).
CORRELATIONS OF OX40L C AND HS-CRP C WITH CORONARY ARTERY STENOSES
There was a significant relationship between the number of complex lesions and the OX40L c level (r = 0.526, P < 0.001) and the 
Discussion
OX40L, originally termed glycoprotein 34 kDa (GP34), and its cognate receptor OX40 belong to the tumour necrosis factor (TNF) and TNF receptor superfamilies, respectively. 17, 18 OX40-OX40L interactions have been shown to be crucial for T-cell activation and survival, and for the generation of memory T cells from activated effector T cells. 19 CRP immunoreactivity has been shown to be associated with the progression of atherosclerosis, especially with unstable coronary plaques, 20 and CRP might lead to rapid and frequent arterial thrombosis in human CRP-transgenic mice. 21 Until now, however, little research has addressed the functions of OX40L a , OX40L c , hs-CRP a and hs-CRP c in patients with ACS.
The results of this study demonstrated that OX40L and hs-CRP levels increased as clinical severity increased from SA to ACS; in addition, the levels of OX40L c and hs-CRP c were significantly higher than OX40L a and hs-CRP a . We speculate that hs-CRP in patients with CAD reflects the activity of endothelial cells in local coronary plaque, which might result in higher levels of adhesion molecules, proinflammatory cytokines and monocyte chemotactic protein-1 22, 23 in the circulation during plaque rupture. Circulating plasma soluble OX40L may pass through damaged atherosclerotic endothelium and come into direct contact with cells inside the lesion, so that inflammation of local coronary plaque is increased.
In the present study, an elevated OX40L c level had a significantly higher discriminatory power than hs-CRP c with respect to ACS. We suggest that OX40L c may have a more direct involvement in plaque destabilization and, thus, a stronger link with ACS. The present study detected a positive correlation between levels of OX40L and hs-CRP in patients with ACS, which is in accordance with a previous study by Haverkate et al. 24 indicating that OX40L might be an additional marker and/or consequence of systemic inflammation. Liu et al. 13 found that patients with ACS showed increased expression of the OX40L system (i.e. OX40L on platelets and in serum), which may create a proinflammatory milieu that aggravates the development of atherosclerosis.
An elevated fibrinogen concentration in persons aged 25 -37 years has been shown to be independently associated with subclinical cardiovascular disease in the subsequent decade of life. 25 In the present study, the fibrinogen level was found to be significantly higher in the ACS group than in the SA group, was significantly higher overall in CAD patients compared with healthy controls and was positively associated with OX40L and hs-CRP levels. To our knowledge, this is the first study to evaluate the relationship between OX40L and hs-CRP levels and fibrinogen level in different tissues (coronary plaque and femoral artery blood). In addition to its fundamental role in haemostasis, fibrinogen acts on adhesion molecules, stimulates cell migration, is a vasoconstrictor and stimulates platelet aggregation. 26 This study has several limitations. First, it was conducted at a single centre and the number of cases was relatively small and, secondly, it was not possible to assess longterm effects on atherosclerotic progression and the scale of in-stent restenosis. Thus, a further study should evaluate a larger
